(Created page with "{{Infobox drug reference | trade_names = | drug_class = | drug_class_color = | uses =Induction of asystole, diagnostic workup and treatment of supraventricular tachycardia...")
 
m
Line 2: Line 2:
| trade_names =  
| trade_names =  
| drug_class =  
| drug_class =  
| drug_class_color =  
| drug_class_color = cardiovascular_antagonist
| uses =Induction of asystole, diagnostic workup and treatment of supraventricular tachycardia  
| uses = Induction of asystole, diagnostic workup and treatment of supraventricular tachycardia
| contraindications =  
| contraindications =  
| routes =Intravenous  
| routes = Intravenous
| dosage =Induction of asystole:
| dosage = Induction of asystole:
* Initially 0.3-0.4 mg/kg IV rapid push
* Initially 0.3-0.4 mg/kg IV rapid push
* If inadequate effect, double dose q30s-1m, up to 2 mg/kg IV  
* If inadequate effect, double dose q30s-1m, up to 2 mg/kg IV
|mechanism=|adverse_effects=|time_onset=|duration=|metabolism=|halflife_redistribution=|halflife_elimination=|clearance=|protein_binding=}}
| mechanism =  
| adverse_effects =  
| time_onset =  
| duration =  
| metabolism =  
| halflife_redistribution =  
| halflife_elimination =  
| clearance =  
| protein_binding =  
}}


Provide a brief summary of this drug here.
Provide a brief summary of this drug here.

Revision as of 00:56, 30 March 2022

Adenosine
Clinical data
Uses

Induction of asystole, diagnostic workup and treatment of supraventricular tachycardia

Routes of administration

Intravenous

Dosage

Induction of asystole:

  • Initially 0.3-0.4 mg/kg IV rapid push
  • If inadequate effect, double dose q30s-1m, up to 2 mg/kg IV
Pharmacodynamics
Pharmacokinetics
Physical and chemical data
Article quality
Editor rating
Unrated
User likes
0

Provide a brief summary of this drug here.

Uses

Contraindications

Absolute contraindications

Precautions

Pharmacology

Pharmacodynamics

Mechanism of action

Adverse effects

Pharmacokinetics

Chemistry and formulation

History

References